EUVIMEDEUVIMED entdecken
Crossref

Identification of acute myeloid leukemia by infrared difference spectrum of peripheral blood

Leiying Xie, Jie Wang, Na Wang, Jianguo Zhu, Qianqian Yin, Ruobing Guo, Junli Duan, Shaowei Wang, Changning Hao, Xuechu Shen

Journal of Pharmaceutical and Biomedical Analysis · 2023-09 · 233 · 115454

DOI: 10.1016/j.jpba.2023.115454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2023-09. Verfasst von Leiying Xie und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Infrared Physics, Shanghai Institute of Technical Physics, Chinese Academy of Sciences, Shanghai 200083, China; School of Phy…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) is a high mortality and recurrence rates hematologic malignancy. Thus, whatever early detection or subsequent visit are both of high significance. Traditional AML diagnosis is conducted via peripheral blood (PB) smear and bone marrow (BM) aspiration. But BM aspiration is a painful burden for patients especially in early detection or subsequent visit. Herein, the use of PB to evaluate and identify the leukemia characteristics will be an attractive alternative source for early detection or subsequent visit. Fourier transform infrared spectroscopy (FTIR) is a time- and cost-effective approach to reveal the disease-related molecular features and variations. However, to the best of our knowledge, there is no attempts using infrared spectroscopic signatures of PB to replace BM for identifying AML. In this work, we are the first to develop a rapid and minimally invasive method to identify AML by infrared difference spectrum (IDS) of PB with only 6 characteristic wavenumbers. We dissect the leukemia-related spectroscopic signatures of three subtypes of leukemia cells (U937, HL-60, THP-1) by IDS, revealing biochemical molecular information about leukemia for the first time. Furthermore, the novel study links cellular features to complex features of blood system which demonstrates the sensitivity and specificity with IDS method. On this basis, BM and PB of AML patients and healthy controls were provided to parallel comparison. The IDS of BM and PB combined with principal component analysis method revealing that the leukemic components in BM and PB can be described by IDS peaks of PCA loadings, respectively. It is demonstrated that the leukemic IDS signatures of BM can be replaced by the leukemic IDS signatures of PB. In addition, the IDS signatures of leukemia cells are reflected in PB of AML patients with peaks of 1629, 1610, 1604, 1536, 1528 and 1404 cm-1 for the first time as well. To this end, we access the leukemic signatures of IDS peaks to compare the PB of AMLs and healthy controls. It is confirmed that the leukemic components can be detected from PB of AML and distinguished into positive (100%) and negative (100%) groups successfully by IDS classifier which is a novel and unique spectral classifier. This work demonstrates the potential use of IDS as a powerful tool to detect leukemia via PB which can release subjects' pain remarkably.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteHumansCell Line, TumorBone Marrow

Stichwörter der Autor:innen

Bone marrowDifference spectrumLeukemia detectionPeripheral blood

Autor:innen und Institutionen

  • State Key Laboratory of Infrared Physics, Shanghai Institute of Technical Physics, Chinese Academy of Sciences, Shanghai 200083, China; School of Physical Science and Technology, ShanghaiTech University, Shanghai 201210…
  • The Hematological Dept. Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • State Key Laboratory of Infrared Physics, Shanghai Institute of Technical Physics, Chinese Academy of Sciences, Shanghai 200083, China; University of Chinese Academy of Sciences, Beijing 100049, China.
  • State Key Laboratory of Infrared Physics, Shanghai Institute of Technical Physics, Chinese Academy of Sciences, Shanghai 200083, China.
  • Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, §School of Physical Science and Technology, ShanghaiTech University, Shanghai 201210, China.
  • Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine, Kongjiang Road 1665, Shanghai 200092, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Chinese Academy of Sciences

Zitieren

APA

Xie, L., Wang, J., Wang, N., Zhu, J., Yin, Q., Guo, R., Duan, J., Wang, S., Hao, C., & Shen, X. (2023). Identification of acute myeloid leukemia by infrared difference spectrum of peripheral blood. Journal of Pharmaceutical and Biomedical Analysis, 233, 115454. https://doi.org/10.1016/j.jpba.2023.115454

Vancouver

Xie L, Wang J, Wang N, Zhu J, Yin Q, Guo R, et al. Identification of acute myeloid leukemia by infrared difference spectrum of peripheral blood. Journal of Pharmaceutical and Biomedical Analysis. 2023;233:115454. doi:10.1016/j.jpba.2023.115454

BibTeX
@article{Xie2023,
  author = {Xie, Leiying and Wang, Jie and Wang, Na and Zhu, Jianguo and Yin, Qianqian and Guo, Ruobing and Duan, Junli and Wang, Shaowei and Hao, Changning and Shen, Xuechu},
  title = {Identification of acute myeloid leukemia by infrared difference spectrum of peripheral blood},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2023},
  volume = {233},
  pages = {115454},
  doi = {10.1016/j.jpba.2023.115454}
}
Kostenlos starten →